Background
Over the past ten years, CRACK IT Challenges has spearheaded the development of innovative 3Rs technologies through a growing portfolio of products and services that deliver improved scientific data, more predictive models and reduce the reliance on animals. From non-invasive home cage monitoring and human relevant stem cell models to in silico platforms, approaches developed through CRACK IT are delivering real world scientific and 3Rs benefits across multiple industry sectors and in basic research.
CRACK IT products can be found on our Innovation Platform and case studies highlighting some of our successes are showcased in our 10 years of CRACK IT: Webinar series.
2021 Challenge launch
This webinar will launch the 2021 CRACK IT Challenge 40: Virtual Second Species.
Our first Mega-Challenge aims to apply advanced computational and mathematical modelling approaches including Machine Learning, systems biology, systems toxicology and multi-scale modelling to develop a suite of virtual dog tissues and organs to model toxicological endpoints for new medicines. The model developed will provide a tool to start moving towards replacing the use of the dog as a second species in drug development.
This is a Three Phase Mega-Challenge sponsored by Bayer AG, Eli Lilly and Company, Genentech Inc., Gilead Sciences Inc., GSK, Merck Healthcare KGaA and Roche and co-funded by EPSRC. Further information about this Challenge can be found on the NC3Rs Innovation Platform.
This webinar will give you an opportunity to learn more about the competition, ask the Sponsors questions and find out how to submit a competitive application.